Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1335
| Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1056 | Recombinant Human CX3CR1 Protein (Fc Tag) (AC1056) | 50 µg | inquiry |
| ACPP-1143 | Recombinant Human Adenosine Receptor A2a Protein (Fc Tag) (AC1143) | 50 µg | inquiry |
| ACPP-1457 | Rat NME2 Protein (AC1457) | 5 µg | inquiry |
| ACPP-1410 | Human MEOX2 Protein (AC1410) | 2 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1776 | Human Acrp30 Protein, HMW (AC1776) | 2 µg | inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
| ACPP-1691 | Human MGLL Protein (AC1691) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.